Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$415K Sell
3,476
-1,096
-24% -$144K 0.01% 1047
2025
Q4
$629K Sell
4,572
-193
-4% -$27.8K 0.01% 818
2025
Q3
$703K Buy
4,765
+1,241
+35% +$172K 0.01% 762
2025
Q2
$456K Sell
3,524
-126
-3% -$15.3K 0.01% 940
2025
Q1
$436K Sell
3,650
-204
-5% -$25.3K 0.01% 908
2024
Q4
$448K Sell
3,854
-3,159
-45% -$399K 0.01% 963
2024
Q3
$943K Buy
7,013
+2,461
+54% +$329K 0.01% 594
2024
Q2
$600K Buy
4,552
+2,847
+167% +$387K 0.01% 735
2024
Q1
$220K Buy
+1,705
New +$206K 0.01% 602

Other funds holding XYL

Choreo LLC's XYL Position: Q1 2026 in Review

Choreo LLC reduced its Xylem (XYL) stake by 24% in Q1 2026, selling an estimated $144K and leaving 3,476 shares worth $415K. The position accounts for 0.01% of the portfolio, ranked #1047.

Choreo LLC first reported a position in XYL in Q1 2024 and has held it in 9 quarters since. The position peaked at $943K in Q3 2024. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Choreo LLC held 3,476 shares of Xylem worth $415K as of Q1 2026.
  • Choreo LLC sold 1,096 Xylem shares in Q1 2026, an estimated $144K.
  • Xylem made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #1047 holding.
  • Choreo LLC first reported a position in Xylem in Q1 2024 and has held it in 9 quarters since.
  • Choreo LLC's Xylem position peaked at $943K in Q3 2024.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.